Outpatient Brexucabtagene Autoleucel in B-Cell Acute Lymphoblastic Leukemia and Mantle Cell Lymphoma

Study investigated outpatient treatment of CAR-T Brexucabtagene autoleucel for treatment of mantle cell lymphoma